MedTrace Logo

Dexmedetomidine Versus Magnesium Sulfate as Adjuvants to Intraperitoneal Bupivacaine for Postoperative Analgesia After Elective Laparoscopic Cholecystectomy

NCT06879288 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-03-17

No results posted yet for this study

Summary

This study aimed to assess the efficiency of dexmedetomidine against magnesium sulfate as adjuvants to intraperitoneal bupivacaine for postoperative analgesia in individuals having elective laparoscopic cholecystectomy.

Conditions

  • Dexmedetomidine
  • Magnesium Sulfate
  • Adjuvants
  • Intraperitoneal Bupivacaine
  • Postoperative Analgesia
  • Elective Laparoscopic Cholecystectomy

Interventions

DRUG

Bupivacaine

Patients received intraperitoneal bupivacaine only at the end of the operations.

DRUG

Dexmedetomidine

Patients received intraperitoneal bupivacaine plus dexmedetomidine at the end of the operations.

DRUG

Magnesium sulfate

Patients received intraperitoneal bupivacaine plus magnesium sulfate at the end of the operations.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06879288 on ClinicalTrials.gov